Syncona Limited Director Declaration (8659P)
22 Junio 2022 - 11:21AM
UK Regulatory
TIDMSYNC
RNS Number : 8659P
Syncona Limited
22 June 2022
Syncona Limited (the "Company")
Director Declaration
22 June 2022
In accordance with the requirements of the Listing Rule 9.6.14R,
the Company advises the following change to directorships in other
publicly quoted companies, held by the following member of the
Board:
Virginia Holmes was appointed to Murray International Trust PLC
on 22 June 2022.
Enquiries
Syncona Ltd
Andrew Cossar
Tel: +44 (0) 20 3981 7940
Citco Fund Services (Guernsey) Limited
Company Secretary
Tel: +44 (0) 1481 758200
About Syncona:
Syncona is a leading FTSE250 healthcare company whose purpose is
to invest to extend and enhance human life by founding and building
a portfolio of global leaders in life science to deliver
transformational treatments to patients in areas of high unmet
need.
Our strategy is to found, build and fund companies around
exceptional science to create a diversified portfolio of 15-20
globally leading healthcare businesses for the benefit of all our
stakeholders. We focus on developing treatments for patients by
working in close partnership with world-class academic founders and
management teams. Our balance sheet underpins our strategy enabling
us to take a long-term view as we look to improve the lives of
patients with no or poor treatment options, build sustainable life
science companies and deliver strong risk-adjusted returns to
shareholders.
Copies of this press release, a company results presentation,
and other corporate information can be found on the company website
at: www.synconaltd.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RDNQLLFLLQLLBBB
(END) Dow Jones Newswires
June 22, 2022 12:21 ET (16:21 GMT)
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024